| EPB0180 | Characteristics and management of ocular involvement in a large cohort of individuals with Mpox disease | E-poster | Co-morbidities |
| OAC0103 | Characterising HIV incidence among people who inject drugs engaged with harm-reduction programs in four provinces in South Africa | Oral abstract session with live Q&A | Epidemiology of HIV |
| EPA0072 | Characterisation of HIV latency and reactivation in human macrophages | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPB0226 | Changes in weight and body mass index associated with dolutegravir- and non-dolutegravir-based antiretroviral treatment regimens: a longitudinal analysis | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0168 | Changes in weight after switching from ritonavir-boosted protease inhibitors to dolutegravir/tenofovir alafenamide/emtricitabine: results from a single arm, open-label, phase 3 clinical trial study (SPIRITED) | E-poster | Co-morbidities |
| EPB0159 | Changes in symptoms of depression and anxiety over time in a cohort of people with HIV initiating HIV care in Cameroon | E-poster | Co-morbidities |
| EPC0527 | Changes in resilience among older PLWH in Ukraine during the COVID-19 pandemic and the Russian invasion | E-poster | Epidemiology of COVID-19 |
| EPE1010 | Changes in HIV service utilization and care outcomes during the first year of the COVID-19 pandemic in Central Africa IeDEA sites | E-poster | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |
| EPC0362 | Changes in HIV pre-exposure prophylaxis prescriptions and sexual health screening before and during the COVID-19 pandemic in a Boston community health center | E-poster | HIV prevention research |
| EPC0452 | Changes in county-level access to medications for opioid use disorder for medicare beneficiaries following medicare-coverage of Methadone treatment in the US | E-poster | Population-specific interventions for HIV prevention |